The Effect of Dopamine and Noradrenaline Antagonists on Amphetamine Induced Locomotor Activity in Mice and Rats

Wiley - Tập 33 Số 5-6 - Trang 385-399 - 1973
Z Roliński1, Jørgen Scheel‐Krüger1
1Department of Pharmacology and Toxicology, The Royal Veterinary and Agricultural College, Copenhagen, and Central Laboratory, Sct. Hans Hospital, 4000 Roskilde, Denmark

Tóm tắt

Abstract: The effect of noradrenaline antagonists, aceperone, phenoxybenzamine and dihydroergotamine and neuroleptic drugs with dopamine receptor blocking properties, i. e. haloperidol, perphenazine, trifluperazine, spiramide and pimozide was tested on the locomotor and rearing activity induced by amphetamine, 2.5 mg/kg, in rats. In general it was found that the neuroleptic drugs in very low doses, haloperidol, 0.10 mg/kg; perphenazine, 0.05 mg/kg; trifluperazine, 0.15 mg/kg; spiramide, 0.05 mg/kg and pimozide, 0.15 mg/kg produced complete inhibition of the amphetamine activities, whereas much higher doses of aceperone, 20 mg/kg and phenoxybenzamine, 20 mg/kg only produced partial antagonism. Dihydroergotamine (20 mg/kg) produced no significant effect on the amphetamine locomotor and rearing activity. In mice trifluperazine (0.2 and 0.4 mg/kg) produced a very marked inhibitory effect, whereas spiramide (0.15 and 0.20 mg/kg) produced a significant but short‐lasting effect on the locomotor activity after 4 and 8 mg/kg d‐amphetamine. Aceperone (5 and 10 mg/kg) and phenoxybenzamine (10 mg/kg) also produced a strong antagonistic effect on the motility. Furthermore α‐methyltyrosine (250 and 350 mg/kg), an inhibitor of the biosynthesis of dopamine and noradrenaline, produced complete inhibition, whereas FLA‐63 (20 and 40 mg/kg), an inhibitor of the formation of noradrenaline produced partial inhibition. In conclusion these results indicate that the locomotor effect in mice and rats after amphetamine is dependent on both dopaminergic and noradrenergic mechanisms. However, dopamine may be regarded as most significant, since the amphetamine motility only seems possible in the presence of functional active dopamine receptors.

Từ khóa


Tài liệu tham khảo

10.1016/0024-3205(64)90196-1

10.1016/0014-2999(70)90006-3

10.1016/0024-3205(70)90207-9

10.1111/j.2042-7158.1972.tb08961.x

Aigner A., 1967, Beeinflussung der Gehirn‐Katecholamine, der Spontanaktivität und der L‐DOPA‐Hyperaktivität durch Diäthyldithiocarbamat, Med. Pharmacol. Exp., 17, 576

10.1111/j.1600-0773.1968.tb00457.x

Carlsson A., 1963, Effect of chlorpromazine or haloperidol on formation of 3‐methoxytyramine and normetanephrine in mouse brain, Acta pharmacol. et toxicol., 20, 140, 10.1111/j.1600-0773.1963.tb01730.x

10.1016/0006-8993(70)90185-X

Dominic J. A., 1969, Acute effects of α‐methyltyrosine on brain catechol‐amine levels and on spontaneous and amphetamine‐stimulated motor activity in mice, Arch. int. Pharmacodyn., 178, 166

Ferris R. M., 1972, A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol. Exp. Therap., 181, 407

10.1007/BF00401348

10.1007/BF02190114

Fuxe K., 1970, International symposium on amphetamines and related compounds, 257

Glowinski J., 1970, International symposium on amphetamines and related compounds, 301

Janssen P. A. J., 1965, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data?, Arzneimittel-Forschung, 15, 104

Janssen P. A. J., 1967, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data?, Arzneimittelforsch., 17, 841

10.1111/j.2042-7158.1967.tb08101.x

Maj J., 1972, Pharmacologic action of d‐ and I‐amphetamine, Dissert. Pharm. Pharmacol., 24, 7

10.1016/0024-3205(72)90198-1

10.1016/0006-2952(69)90150-6

Munoz C., 1961, Influence of adrenergic blocking drugs upon the EEG analeptic effect of dl‐amphetamine in conscious unrestrained rabbits, J. Pharmacol. Exp. Therap., 132, 354

10.1111/j.1476-5381.1970.tb08517.x

10.1111/j.1600-0773.1972.tb03612.x

10.1111/j.2042-7158.1966.tb07861.x

10.1038/211540a0

Randrup A., 1970, International symposium on amphetamines and related compounds, 695

10.1111/j.2042-7158.1966.tb07799.x

10.1111/j.1600-0773.1963.tb01731.x

10.1111/j.2042-7158.1965.tb07646.x

Rossum J. M.van:The significance of dopamine‐receptor blockade for the action of neuroleptic drugs. In: Proc. 5th intern. Congress Collegium Intern. Neuropsychopharmacologium. Washington1966. Encerpta Medica Intern. Series No. 129 321–329.

10.1016/S0074-7742(08)60065-3

10.1016/0024-3205(67)90186-5

10.1016/0014-2999(71)90121-X

10.1016/0014-2999(72)90132-X

Scheel‐Krüger J., 1972, Some aspects of the mechanism of action of various stimulant amphetamine analogues, Psychiat. Neurol. Neurochir. (Amst.), 75, 179

Scheel‐Krüger J., 1972, Studies on the accumulation of 0‐methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone, Arch. int. Pharmacodyn., 195, 372

10.1016/0028-3908(70)90074-2

10.1016/0014-2999(70)90061-0

10.1007/BF00998578

10.1007/BF00403689

10.1007/BF00402762

10.1126/science.168.3938.1487

10.1016/0006-8993(71)90661-5

Weissman A., 1966, Antiamphetamine effects following inhibition of tyrosine hydroxylase, J. Pharmacol. Exp. Therap., 151, 339